drugset / Trial / NCT04104503
A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects
RandomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to investigate the extent to which Lu AF11167 enters the bloodstream following tablet intake and the influence of food on uptake in healthy men and women
Timeline
- Start
- 2019-09-17
- Primary completion
- 2020-04-09
- Completion
- 2020-04-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lu AF11167 | Unknown | 1 mg | Intravenous |
| Subject | Lu AF11167 | Unknown | 2 mg | Intravenous |
Indications
No indication recorded.